Navigation Links
Revolutionary Device for Premature Ejaculation Treatment
Date:9/6/2012

LONDON, September 6, 2012 /PRNewswire/ --

A newly approved treatment for men experiencing premature ejaculation (PE) was unveiled at the World Congress of Sexual Medicine in Chicago on Monday, the 27th of August 2012.

     (Photo: http://photos.prnewswire.com/prnh/20120906/559405 )

Dr Andy Zamar presented climax control training device and programme Prolong TM, which has been found to prolong the time to ejaculation by an average 11 fold.

The device, to be used in conjunction with the start-stop technique, is: substantially cheaper than current available treatments for PE; free from side effects; provides long-term effects; and requires no prescription or medical consultations.

Prolong TM was developed in 2008, after independent clinical trials in London University Teaching Hospitals in 2004, where the prototype in conjunction with the programme was compared to an active control, the Gold Standard treatment, rather than a placebo. In the trial, 61 per cent of men reported lasting 11 times longer during intercourse after using Prolong, compared to three fold improvements in 40 per cent of men who had undergone Teaching Hospital standard Psychosexual Therapy.

Creator and Harley Street Psychiatrist Dr Zamar said:

"Roughly 30% of men experience premature ejaculation at some point in their lives. While there are a number of current treatments available including Psychosexual Therapy, SSRIs and local anaesthetics, I realised there was a need for an effective, discreet, side effect free and affordable treatment that's easy to access.

"The independent clinical trials have proven the benefits Prolong can make to the lives of men and, subsequently, their partners, so hopefully the availability of the device will mark the beginning of the end to the suffering caused by premature ejaculation."

In light of the clinical trial results, Dr Zamar recommended that Prolong TM should be the first line treatment for PE as well as used alongside other treatments, as the programme has no harmful effects. The presentation was peer reviewed and was published in the August issue of the Journal of Sexual Medicine in the proceedings of the World Meeting on Sexual Medicine 2012.

Prolong TM is an approved treatment for climax control in Europe, available on the Internet at http://www.aboutpe.com and in the UK from April 2012.

Note to Editors:

  • Prolong costs £160 while Psychosexual Therapy costs £600-£800 ($945-$1250/€765-€1025).
  • Based on the expected large effect size of Prolong TM and a study power of 80% (the globally accepted clinical trial standard), it was calculated that 52 participants were to be enrolled in the clinical trial.
  • Comparing the effect sizes of Prolong TM with other effective treatments- Antidepressants have an effect size in the treatment of depression of 0.31, local anaesthetics and antidepressants have an effect size of between three and six in the treatment of PE, whilst Prolong has an effect size of 11 for the treatment of PE, making Prolong TM 2-3.5 times more effective than other treatments for PE.
  • Benefits were noted at week one, were maximal at week six and lasted at least three months after the programme was completed.
  • Prolong is approved in the 31 countries of the European Economic Area, for Climax Control training as a Class II a medical device.


'/>"/>
SOURCE The London Psychiatry Centre
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta to Showcase Revolutionary Agility Beam-shaping Innovation at Radiation Physics Annual Meeting
2. China Health Resource Develops Revolutionary Migraine Medication
3. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
4. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
5. Brazil Orthopedic Devices Market Outlook to 2018 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
6. Global Peripheral Vascular Devices Market 2011-2015
7. Nelson Laboratories to Present Latest FDA Trends at MEDevice Forum San Diego
8. Institut Curie Acquires Four Advanced Radiotherapy Treatment Systems Including Three Varian TrueBeam Devices
9. Governor Corbett: Pharmaceutical and Medical Device Packaging Company to Create New Jobs in Lehigh Valley
10. Global Airway Management Devices Industry
11. MarketsandMarkets: Sports Medicine Devices Market is expected to reach $5.7 billion by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... the only authorized OSHA Training Institute Education Center headquartered in Northern California, has ... workers from extreme heat at their worksites. Employers with workers exposed to ...
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... health professionals, announced today its affiliation with Tennessee Counseling Association. This ... the network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
Breaking Medicine News(10 mins):